ELVN Enliven Therapeutics Inc

held by 1 manager in Q3 2025

Manager	% of their portfolio	Held	Activity	Value	Shares
Stanley Druckenmiller Duquesne Family Office	0.49%	6 mo	Add ×2.0	$19M	947,405

Search